“Most market participants chase alpha but get risks, while one could chase safety and get alpha"
The Science of Alpha from Safety
OmniScience Capital is a Global Investment Management firm specializing in global equity investments empowered by its proprietary Scientific Investing Philosophy. OmniScience Capital was founded with a view to bring a scientific approach to investment management. The core insight on which OmniScience Capital is based, i.e. the OmniInsight, is that a systematic approach to enhancing safety, i.e. eliminating and mitigating the chances of permanent loss of capital, naturally leads to enhancing returns and generating alpha.
Global by Design
OmniScience’s vision is to provide global investors with global opportunities via SuperNormal Portfolios for US, Europe, India and Transformative Technologies.
OmniScience pioneered global investing (US and Technology investing) for Indian investors via SuperNormal Portfolios. OmniScience helps non-Indian investors to invest in the US and Indian markets. Given that technology, especially, digital transformation technologies, such as, Artificial Intelligence, Internet of Things, 5G, Cloud, Big Data etc. are transforming businesses and the global economy, transformative technology investing in listed global companies is another focus area at OmniScience.
OmniScience also helps global investors to invest in the Indian equity markets through SuperNormal Portfolios.
Enhance Safety, Enhance Growth, Enhance Returns
Scientific Investing creates a SuperNormal Portfolio designed to survive and thrive through uncertainties, delivering optimal “Return on Safety".
It is based on a deep immersive research and analysis of 100+ years of investment management history combined with experience of investing over multiple cycles across different markets. OmniInsight emerged from the above research and is at the crux of the Scientific Investing Philosophy and the resulting framework. It builds upon ideas and insights from before Benjamin Graham to John Burr Williams to Warren Buffett, Peter Lynch and several others.
In brief, the Scientific Investing Framework selects SuperNormal Companies at SuperNormal Prices creating a SuperNormal Portfolio.
The investment focus of OmniScience Capital is on the US equity markets, the Indian equity markets and Transformative Technology.
The following are the 4 core strategies offered by OmniScience Capital:
US Multi-cap Allocation
US Artificial Intelligence Allocation
India Multi-cap Allocation
India Digital Transformation Allocation
The team is led by Dr. Vikas V Gupta who provides the philosophical foundation for the Scientific Investing Framework. He heads the invest strategy function and works with the portfolio management team to oversee the current portfolios. He also supervises the research function and works with the research team to develop new investment strategies.
Ashwini Shami leads the portfolio management and manages the client portfolios.
Varun Sood leads the research on developing and maintaining the Scientific Investing research platform which generates the existing and new investment strategies.
SEBI Complaints Disclosure
At the beginning of the month: 0
Received during the month: 0
Resolved during the month: 0
Pending at the end of the month: 0
Reasons for pendency: NA
Omniscience Investment Adviser is the advisory division of Omniscience Capital Advisors Pvt.Ltd. which is registered as a non-individual Investment Adviser with SEBI with a valid registration No. INA000007623, BASL Membership Id 1197 and CIN U93000MH2017PTC290053. Principal Officer is Vikas V Gupta (Contact No. 9987681967, Email: firstname.lastname@example.org) and Compliance Officer is Ashwini Kumar Shami (Contact No. 9892140540, Email: email@example.com). Grievance Officer is Mahir Shah (Contact No. 9029202759, Email: firstname.lastname@example.org). Local office address of Securities and Exchange Board of India is SEBI Bhavan, C4-A, G Block, BKC, Mumbai - 400 051.
Address: Awfis | 1st Floor | B Wing | Parinee Crescenzo | G-Block | BKC | Mumbai - 400051
Phone: (+91) 90045 60540
Compliance Audit Status
|Compliance Audit Status
|Remarks, If any